About 39% of men and women will be diagnosed with cancer at some point in their lifetime. That means roughly 2 in 5 people will face a cancer diagnosis, making it one of the most common serious illnesses worldwide. In 2022 alone, an estimated 20 million new cancer cases were diagnosed globally, and nearly 10 million people died from the disease.
Lifetime Risk by the Numbers
Based on 2021–2023 data from the National Cancer Institute, approximately 39.2% of Americans will receive a cancer diagnosis during their lifetime. That figure covers all cancer types combined. In the United States, about 18.6 million people are currently living with or beyond a cancer diagnosis, representing roughly 5.4% of the population at any given time.
Globally, cancer accounted for 20 million new cases and 9.7 million deaths in 2022. To put those numbers in perspective, cancer is second only to heart disease as a leading cause of death worldwide.
Age Is the Biggest Factor
Cancer is overwhelmingly a disease of older adults. The median age at diagnosis is 67, and incidence climbs steeply with each decade of life. Among people under 20, rates sit below 26 cases per 100,000. By ages 45 to 49, that rises to about 350 per 100,000. Past age 60, rates exceed 1,000 per 100,000.
The age distribution of new diagnoses tells the same story:
- Under 20: 0.9% of all new cases
- 20 to 44: 7.6%
- 45 to 64: 33.6%
- 65 to 84: 50.7%
- Over 84: 7.3%
The peak window is ages 65 to 74, which accounts for nearly a third of all new cancer diagnoses. Childhood cancer is rare in absolute terms, representing only about 1% of all cases, though certain types like bone cancer and brain tumors are diagnosed in children at disproportionately higher rates than in adults.
The Most Common Types
Not all cancers are equally common. In the U.S., projected new cases for 2026 show a clear top five:
- Prostate: 333,830 new cases
- Breast: 324,580
- Lung and bronchus: 229,410
- Colon and rectum: 158,850
- Melanoma (skin): 112,000
Prostate and breast cancer together account for more new diagnoses than the next three types combined. Lung cancer, while third in incidence, remains the deadliest cancer type by a wide margin.
Cancer Rates Vary Dramatically by Country
Where you live has a major influence on cancer risk. Age-adjusted rates (which account for differences in population age) range from as low as 36 per 100,000 people in Sierra Leone to 462 per 100,000 in Australia. The countries with the highest rates include Australia, New Zealand, Denmark, the United States (367 per 100,000), and Norway.
These gaps don’t simply mean people in wealthier countries get more cancer. Higher-income nations have better screening programs, which catch cancers that might go undiagnosed elsewhere. They also have older populations on average, and age is the single strongest risk factor. Lifestyle factors common in wealthier nations, like higher rates of obesity, alcohol consumption, and sun exposure, also play a role. Meanwhile, lower-income countries often have higher rates of infection-related cancers, such as cervical and liver cancer, but lower rates of cancers tied to Western lifestyles.
Income and Education Shift the Picture
Even within a single country, cancer doesn’t affect everyone equally. The relationship between socioeconomic status and cancer is more nuanced than you might expect. For lung cancer, the link is straightforward: men without a high school education develop lung cancer at roughly three times the rate of college-educated men, and women without a high school diploma have about twice the rate. Lower income tells a similar story, with people earning under $12,500 per year developing lung cancer at 1.7 times the rate of those earning $50,000 or more. This tracks closely with smoking rates, which remain highest in lower-income populations.
For prostate and breast cancer, the pattern actually reverses. People with higher education and income are diagnosed more often, likely because they have greater access to screening that detects cancers early. But here’s the critical difference: when lower-income individuals do develop breast or prostate cancer, they’re far more likely to be diagnosed at a late stage. Women in the lowest income groups face 2.3 times the odds of a late-stage breast cancer diagnosis compared to the highest income group. Getting cancer is one thing; catching it early enough to treat effectively is another.
What These Numbers Mean for You
A 39% lifetime risk sounds alarming, but it’s important to understand what that number includes. It spans every type of cancer, from highly treatable skin cancers to aggressive forms of the disease. It also reflects a population that lives long enough for age-related cancers to develop. Someone who lives to 90 has had many more decades of cellular division, and more opportunities for the kind of DNA errors that lead to cancer, than someone who dies of heart disease at 55.
The number also doesn’t reflect your individual risk, which depends heavily on factors like age, family history, smoking status, body weight, and alcohol use. A 30-year-old nonsmoker at a healthy weight has a very different risk profile than a 65-year-old with a long smoking history. Roughly half of all cancers are linked to modifiable risk factors, meaning the choices you make throughout your life genuinely shift your odds.
Survival has also improved substantially. The 18.6 million Americans currently living after a cancer diagnosis reflect both how common cancer is and how much more survivable many types have become. For many of the most frequently diagnosed cancers, including breast, prostate, and melanoma, five-year survival rates now exceed 90% when caught early.